Qatar vs South-East Asia (WHO region): Inactivated first-dose polio vaccine (IPV1) immunization coverage
Qatar
99.0%
in 2025
South-East Asia (WHO region)
94.0%
in 2025
Qatar rank
1st
South-East Asia (WHO region) rank
2nd
Inactivated first-dose polio vaccine (IPV1) immunization coverage over time
- Qatar
- South-East Asia (WHO region)
How they compare
Qatar currently reports 99.0% against 94.0% in South-East Asia (WHO region), a difference of 5.0%.
That makes Qatar's figure about 1.1 times South-East Asia (WHO region)'s.
Across all 11 years both countries report, Qatar has been ahead every year.
Qatar ranks 1st and South-East Asia (WHO region) ranks 2nd of 194 countries.
Qatar has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Qatar | South-East Asia (WHO region) | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 98.2% | 52.6% | 45.6% | Qatar |
| 2020s | 97.3% | 89.5% | 7.8% | Qatar |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher inactivated first-dose polio vaccine (ipv1) immunization coverage, Qatar or South-East Asia (WHO region)?
- Qatar, at 99.0% against 94.0% in South-East Asia (WHO region) as of 2025.
- What is the difference in inactivated first-dose polio vaccine (ipv1) immunization coverage between Qatar and South-East Asia (WHO region)?
- 5.0%, with Qatar ahead.
- How many years of comparable data are there for Qatar and South-East Asia (WHO region)?
- 11 years are reported by both, from 2015 to 2025.
- How do Qatar and South-East Asia (WHO region) rank globally for inactivated first-dose polio vaccine (ipv1) immunization coverage?
- Qatar ranks 1st and South-East Asia (WHO region) ranks 2nd of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Inactivated first-dose polio vaccine (IPV1) immunization coverage among 1-year-olds (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.